Danaher Corporation acquired Aldevron, L.L.C. for approximately $9.6 billion cash purchase price, a transaction completed in August 2021, structured as all cash.
Aldevron, L.L.C. operates in Life Sciences (genomic medicine), is based in Fargo, North Dakota, USA. Danaher acquired Aldevron in August 2021 for ~$9.6 billion; Aldevron manufactures high-quality plasmid DNA, mRNA and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications.
On August 30, 2021, the Company acquired Aldevron, L.L.C. (“Aldevron”) for a cash purchase price of approximately $9.6 billion (the “Aldevron Acquisition”). Aldevron manufactures high-quality plasmid DNA, mRNA and proteins, serving biotechnology and pharmaceutical customers across research, clinical and commercial applications.Danaher Corporation FY21 10-K, acquisition note
Advisory firms were not disclosed for this transaction.